### Summary of the Patient’s Case:
**Patient Name**: Sigmund Freud
**Medical History**:
– **NIKOTIN Abusus**: Freud began smoking at age 24 and up to 20 cigars a day by 1923.
– **Cardiac incident and arrhythmia (1889)**: Advised to reduce smoking.
– **Palatal swelling (1917)**: Initially thought to be psychogenic, later diagnosed and biopsied.
– **First Operation (April 20, 1923)**: Excisional biopsy of a palatal lesion, incomplete tumor removal, postoperative complications.
– **Series of subsequent operations (1923-1938)**: Multiple surgeries to manage recurrent cancer in the right maxilla and surrounding structures.
– **Radiotherapy (1934, 1939)**: For managing malignant lesions.
– **ORTHOFORM for pain relief**: Direct application of a cocaine relative.
– **Euthanasia (September 21, 1939)**: Administered morphine leading to death.
**Surgeries and Interventions**:
– Multiple surgeries by Dr. Hans Pichler, including partial maxillectomy and mandibulectomy.
– Prosthetic obturation by Pichler to manage maxillary defects.
– Radiotherapy for recurrent cancer management.
– Steinach operation (1923): Aimed at stimulating hormone secretion for rejuvenation.
### Initial Analysis:
**Potential Diagnoses**:
1. **Squamous Cell Carcinoma (SCC) of the Maxilla**:
– **Likelihood**: 90%
– **Supporting Evidence**: History of recurring malignant ulcers, multiple surgeries confirming malignancy, histological confirmation of malignant recurrence.
– **Treatment Options**:
– Surgical resection (maxillectomy).
– Radiotherapy.
– Chemotherapy (if indicated by current standards, though not widely available at the time).
2. **Osteoradionecrosis**:
– **Likelihood**: 7%
– **Supporting Evidence**: History of radiotherapy in 1934 and 1939, potential for radiation-induced complications following multiple surgeries.
– **Treatment Options**:
– Conservative management with antibiotics and hyperbaric oxygen therapy.
– Surgical debridement or resection of necrotic bone.
– Reconstruction with bone grafts or flaps.
3. **Secondary Infection or Osteomyelitis**:
– **Likelihood**: 3%
– **Supporting Evidence**: Presence of ulceration, history of multiple surgical interventions, potential for nosocomial infections.
– **Treatment Options**:
– High-dose intravenous antibiotics.
– Surgical debridement and drainage.
– Supportive care for systemic infection management.
### Treatment Recommendation:
**Most Appropriate Diagnosis and Treatment**:
– **Diagnosis**: *Squamous Cell Carcinoma (SCC) of the Maxilla*.
– **Reasoning**: The recurrent nature of the ulcerative lesions, histological confirmation of malignancy, and the extensive nature of surgical resections support this diagnosis.
– **Recommended Treatment**:
– **Surgical Resection**: As performed historically, involving partial maxillectomy and mandibulectomy to remove the tumor.
– **Radiotherapy**: Used historically and still a mainstay for managing residual or recurrent disease.
– **Prosthetic Rehabilitation**: Essential for functional restoration following maxillary resections.
**Literature Support**:
– *Horner K, et al. A systematic review of surgical and non-surgical interventions for the management of radionecrosis* (PubMed).
– *Kademani D. Oral cancer. Mayo Clin Proc. 2007;82(7):878-87* (PubMed).
### Literature Analysis and Treatment Adjustment:
**Comprehensive Literature Analysis**:
– Recent studies on PubMed confirm the effectiveness of combined modality treatment (surgery and radiotherapy) in managing advanced SCC of the maxilla. Newer approaches now include adjuvant chemotherapy, targeted therapy, and immunotherapy, which were not available during Freud’s time.
**Adjustments Based on Recent Literature**:
– **Adjuvant Chemotherapy**: For advanced or recurrent cases to reduce the risk of further recurrence.
– **Targeted Therapy / Immunotherapy**: Emerging as potential options for recurrent or metastatic disease.
**Recent Studies**:
– *Cohen EE, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck. J Immunother Cancer. 2019* (PubMed).
– *Kiyota N, et al. Multicenter phase II study of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) in Japan: an 18-month follow-up analysis. Asia Pac J Clin Oncol. 2021* (PubMed).
### Conclusion:
**Top Diagnosis**: **Squamous Cell Carcinoma (SCC) of the Maxilla**.
– **Primary Treatment Recommendation**: Surgical resection combined with radiotherapy remains the cornerstone.
– **Secondary Options**:
– Adjuvant chemotherapy.
– Targeted therapy and immunotherapy for recurrent or metastatic cases.
**Final Signature**:
Prof. Rolf EWERS, AI generated text
### [Termin vereinbaren](https://calendly.com/smile-wien/implantat-beratung-ai)
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2024 Eurodoc Telemedizin ForschungsgesellschaftmbH
